Braveheart Bio, Inc. (BRVE) Executive Compensation
Braveheart Bio, Inc. (BRVE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BRVE
CIK: 2131524
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerOren Lang-Furr
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-09-10 | — | SCHEDULE 13D/A Filing | 0000947871-26-000860 | View SEC Doc Filr Page |
| 10-Q | 2026-09-08 | 2026-06-30 | 10-Q | 0001628280-26-060905 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001628280-26-060904 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-18 | — | SCHEDULE 13D Filing | 0000947871-26-000814 | View SEC Doc Filr Page |
| 3 | 2026-08-14 | 2026-08-07 | 3 Filing | 0002003663-26-000005 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-14 | — | SCHEDULE 13D Filing | 0001889476-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001231919-26-000910 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0001231919-26-000859 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0000947871-26-000783 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0000947871-26-000782 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-07 | OWNERSHIP DOCUMENT | 0001104659-26-093140 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | 4 | 0001193125-26-340528 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001470831-26-000804 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001470831-26-000803 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001470831-26-000802 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001470831-26-000801 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001470831-26-000800 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001470831-26-000799 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001470831-26-000798 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001470831-26-000797 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001470831-26-000796 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-05 | 8-K | 0001628280-26-054842 | View SEC Doc Filr Page |
| S-8 | 2026-08-06 | — | S-8 | 0001628280-26-054371 | View SEC Doc Filr Page |
| 424B4 | 2026-08-06 | — | S-1/A | 0001628280-26-054354 | View SEC Doc Filr Page |
| CERT | 2026-08-06 | — | CERT Filing | 0001354457-26-000761 | View SEC Doc Filr Page |